Investigating differences in treatment effect estimates between propensity score matching and weighting: a demonstration using STAR*D trial data

Pharmacoepidemiol Drug Saf. 2013 Feb;22(2):138-44. doi: 10.1002/pds.3396. Epub 2012 Dec 28.

Abstract

Purpose: The choice of propensity score (PS) implementation influences treatment effect estimates not only because different methods estimate different quantities, but also because different estimators respond in different ways to phenomena such as treatment effect heterogeneity and limited availability of potential matches. Using effectiveness data, we describe lessons learned from sensitivity analyses with matched and weighted estimates.

Methods: With subsample data (N = 1292) from Sequenced Treatment Alternatives to Relieve Depression, a 2001-2004 effectiveness trial of depression treatments, we implemented PS matching and weighting to estimate the treatment effect in the treated and conducted multiple sensitivity analyses.

Results: Matching and weighting both balanced covariates but yielded different samples and treatment effect estimates (matched RR 1.00, 95% CI: 0.75-1.34; weighted RR 1.28, 95% CI: 0.97-1.69). In sensitivity analyses, as increasing numbers of observations at both ends of the PS distribution were excluded from the weighted analysis, weighted estimates approached the matched estimate (weighted RR 1.04, 95% CI 0.77-1.39 after excluding all observations below the 5th percentile of the treated and above the 95th percentile of the untreated). Treatment appeared to have benefits only in the highest and lowest PS strata.

Conclusions: Matched and weighted estimates differed due to incomplete matching, sensitivity of weighted estimates to extreme observations, and possibly treatment effect heterogeneity. PS analysis requires identifying the population and treatment effect of interest, selecting an appropriate implementation method, and conducting and reporting sensitivity analyses. Weighted estimation especially should include sensitivity analyses relating to influential observations, such as those treated contrary to prediction.

Publication types

  • Comparative Study
  • Randomized Controlled Trial
  • Research Support, N.I.H., Extramural

MeSH terms

  • Antidepressive Agents / therapeutic use*
  • Depressive Disorder, Major / drug therapy*
  • Depressive Disorder, Major / epidemiology*
  • Depressive Disorder, Major / psychology
  • Humans
  • Propensity Score*
  • Prospective Studies
  • Statistics as Topic / methods
  • Treatment Outcome

Substances

  • Antidepressive Agents